Contact Us

News

  • Plant 3

    OSD and Injectable Oncology - Verna, Goa - Installation completed and under process validation

    2019-04-08 14:55:31

  • Plant 2

    OSD - Skidel, Belarus Inaugurated on 7-Mar-19. Commercial Licence Obtained in Dec-2019

    2020-01-25 10:12:34

  • Plant 4

    ONCO API, Goa - Building is ready, machine installations in progress

    2019-09-24 17:49:06

  • Fight against Covid-19

    Face mask, Two Yard distance and hand wash is must

    2020-10-16 14:21:39

  • DSIR Approved R&D Centre

    R&D and ADL centre has certified by DSIR, Govt. of India.

    2020-10-16 14:22:49

Quote

  • Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg  And  Favipiravir 200 mg/400mg/800mg Tablet.

Upcoming ONCO Plant for Formulation & API - GOA
Infrastructure
  • Oncology
  • API
  • Manufacturing Facility

The oral dosage facility will commence in the 4th quarter of FY18-19 for validation and thereafter for commercial production. The state-of-art factory is situated 25km ahead from Panjim, capital of Goa. It is well connected by railways Airport, Seaport and roadways.

Buildup area 4000+ Sq.M (Store, QC, Packing, Change rooms, Utility), 3 floor structure made of R.C.C. followed by International GMP guideline having four main segment

  • Tablets
  • Capsules
  • Liquid Suspension & Syrup
  • Ointment & Cream
Locality –

Well Developed Industrial area, which enable Operational work efficiency (sourcing of materials, change parts etc) and Ease of obtaining various services and experts etc.

Utility:

Steam boiler, Air Compressor, DG Set, RO plant, HVAC system, Dehumidifier linked to HVAC system, ETP System

Manpower:

Talented and technical human resource, proximity to Pharmaceutical Collage, employee friendly policies

Logistic -

 

  • Well connected and close to all 3 mode of transportation
  • Surface – National highway 3 KM, Railway 17 KM
  • Air – International Airport 15 KM
  • Water – Mormugao port trust 20 KM

 

Stores:

follow GDP norms